Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients

Journal of Surgical Oncology

Volumn 98, Issue 1, 2008, Pages 46-48

  Glumac, Nebojsa ^a   Hocevar, Marko ^a   Zadnik, Vesna ^a   Snoj, Marko ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Lymphadenectomy; Melanoma; Micrometastases; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROMETASTASIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SLOVENIA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS;

EID: 47149097293     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21066     Document Type: Article

References (18)

1. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
2. Cochran AJ, Balda BR, Starz H, et al.: The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000;15: 89(2) 236-241.
3. Cook MG, Green MA, Anderson B, et al.: The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314-319.
4. Ruiter DJ, Spatz A, van den Oord JJ, et al.: Pathologic staging of melanoma. Semin Oncol 2002;29:370-381.
5. Sondak VK, Taylor JM, Sabel MS, et al.: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004;11:247-258.
6. Thompson JF, Shaw HM: Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy? Ann Surg Oncol 2004;11:233-235.
7. Macripo G, Quaglino P, Caliendo V, et al.: Sentinel lymph node dissection in stage I/II melanoma patients: Surgical management and clinical follow-up study. Melanoma Res 2004;14:S9-12.
8. Chao C, Martin RC, Ross MI, et al.: Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259-264.
9. Su LD, Fullen DR, Lowe L, et al.: Desmoplastic and neurotropic melanoma. Cancer 2004;100:598-604.
10. McMasters KM, Wong SL, Edwards MJ, et al.: Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:137-141.
11. Hocevar M, Bracko M, Pogacnik A, et al.: Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma. Eur J Cancer 2003;39:2173-2178.
12. Hermanek P, Hutter RV, Sobin LH, et al.: International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
13. Carlson GW, Murray DR, Lyles RH, et al.: The amount of metastatic melanoma in a sentinel lymph node: Does it have prognostic significance? Ann Surg Oncol 2003;10:575-581.
14. Starz H, Balda BR, Krämer KU, et al.: A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-2121.
15. van Akkooi AC, de Wilt JH, Verhoef C, et al.: Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: Are these nodes to be considered negative? Ann Oncol 2006;17: 1578-1585.
16. Vuylsteke RJ, Borgstein PJ, van Leeuwen PA, et al.: Sentinel lymph node tumor load: An independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 2005;12:440-448.
17. Dewar DJ, Newell B, Green MA, et al.: The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004;22: 3345-3349.
18. Cochran AJ, Wen DR, Huang RR, et al.: Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004;17: 747-755.